FindTrial
Sign In

ACT for CP Individual Patient Expanded Access IND Protocol

Autologous Cell Therapies for Cerebral Palsy-Chronic (ACT for CP) Individual Patient Expanded Access IND Protocol

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT03203941
Enrollment
Unknown
Registered
2017-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2020-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

Autologous Cord Blood Stem Cells

Brief summary

Individual patient expanded access protocol for a child with cerebral palsy (CP) who has autologous umbilical cord blood available and who is ineligible to participate in other stem cell studies for children with CP.

Detailed description

This protocol is part of an FDA Individual Patient Expanded Access IND submitted at the request of the parents of a child with cerebral palsy (CP) who is ineligible to participate in other stem cell studies. For this child, there are no other treatment options.

Interventions

BIOLOGICALAutologous Cord Blood Stem Cells

This is an individual patient expanded access protocol.

Sponsors

Charles Cox
Lead SponsorOTHER

Eligibility

Inclusion criteria

\-

Exclusion criteria

\-

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026